Delirium, Dementia, Amnestic, Cognitive Disorders  >>  Nine Phase One (mannote sodium)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Nine Phase One (mannote sodium) / Shanghai Greenvalley
NCT01453569: Safety, Efficacy and Dose Titration of Sodium Oligo-mannurarate Capsule on Mild to Moderate Alzheimer's Disease

Completed
2
255
RoW
Sodium oligo-mannurarate 600mg, Sodium oligo-mannurarate low dose, Sodium oligo-mannurarate 900mg, Sodium oligo-mannurarate high dose, Placebo
Shanghai Greenvalley Pharmaceutical Co., Ltd., Shanghai Mental Health Center
Alzheimer Disease, Cognitive Impairment
08/13
08/13

Download Options